Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.52−0.03 (-5.87%)

Close on Nov 12, 2026Market cap $48.56MP/E –Yield –

Citius Oncology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Citius Oncology's total debt was $6.41M at Jun 30, 2026.

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change
Q3 FY2026CQ2 2026	Jun 30, 2026	$6.41M	–

See a number that looks wrong?